Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Key launches and pricing in India: Sun Pharma Launched semaglutide under Noveltreat and Sematrinity - Noveltreat: 900 2,000 per month - Sematrinity: 750 1,300 per month Dr Reddy's Laboratories Launched Obeda - Cost: Around 4,200 per month Glenmark Pharmaceuticals Launched GLIPIQ - Weekly cost: 325 440 Zydus Lifesciences Launched SEMAGLYN, MASHEMA, ALTERME - Average monthly cost: Around 2,200 Natco Pharma + Eris Lifesciences - Starting price: Around 1,290 per month for lowest dose Eli Lilly had already launched competing diabetes and weight loss drugs in India, but usage was largely limited to urban and high-income patients due to high prices
Cold food strategies: Cold chicken or turkey instead of hot
We know
Mounjaro: INN: tirzepatide EPAR Product Information
With specialized expertise in metabolic restoration, he takes a patient-first approach to weight management treating obesity as the complex metabolic condition it is, not a willpower problem
US$ 24.75
US$ 20.56
US$ 28.04
US$ 25.95
US$ 26.07
US$ 29.08
